• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART-VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART-VALVE Back to Search Results
Model Number 3300TFX
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Endocarditis (1834); Sepsis (2067); Insufficient Information (4580)
Event Type  Injury  
Manufacturer Narrative
H10: additional manufacturer narrative: the device was not returned for evaluation.Attempts to retrieve the device and additional information are in process.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
Edwards lifesciences maintains an implant patient registry (ipr).This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional "customer complaint".The information reported may or may not be related to the edwards device.It was reported via the implant patient registry that this valve model 3300tfx23mm implanted in aortic position was explanted from a 73 year old patient after an implant duration no longer than six (6) months and two (2) days for unknown reason.A 21mm surgical aortic valve was implanted in replacement.
 
Event Description
It was reported via the implant patient registry that this valve model 3300tfx23mm implanted in aortic position was explanted from a 73 year old patient after an implant duration of four (4) months and three (3) days due to endocarditis leading to annular abscess.The infecting organism was mssa (meticillin-sensitive staphylococcus aureus).Reportedly, the patient had cellulitis after electromyography (emg) and presented with sepsis.A 21mm surgical aortic valve was implanted in replacement.The patient was noted as to be discharged home.
 
Manufacturer Narrative
Added information to section d6 (explanted date).Updated section b4 (date of this report), b5 (describe event or problem), g3 (date received by manufacturer), h6 (device code(s)) and h6 (health effect - clinical code), h6 (investigation findings) and h6 (investigations conclusions).Corrected h6 (device code(s)) and h6 (health effect - clinical code).H10: additional manufacturer narrative: corrected data: initially, it was reported via the implant patient registry that this valve model 3300tfx23mm implanted in aortic position was explanted from a 73 year old patient after an implant duration no longer than six (6) months and two (2) days for unknown reason.A 21mm surgical aortic valve was implanted in replacement.However, through investigation it was learned that the valve was explanted from this patient after an implant duration of 4 months and 3 days due to endocarditis leading to annular abscess.Reportedly, the patient had cellulitis after electromyography (emg) and presented with sepsis.A valve model 3300tfx21mm was successfully implanted in replacement.The patient was noted as to be discharged home.Based on the additional information obtained, this event is no longer considered reportable and this correction is being submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS
Type of Device
REPLACEMENT HEART-VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
one edwards way
mle fl2 office m2013
irvine, CA 92614
9492506615
MDR Report Key18099344
MDR Text Key327699081
Report Number2015691-2023-17336
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860057
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/09/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number3300TFX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received12/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Life Threatening;
Patient Age73 YR
Patient SexMale
-
-